HLS Therapeutics Brief: Q4 2023 Revenue Was US$15.9 Million, Adjusted EBITDA Was $5.3 Million and Cash From Operations Was $3.7 Million
HLS Therapeutics Brief: Q4 2023 Revenue Was US$15.9 Million, Adjusted EBITDA Was $5.3 Million and Cash From Operations Was $3.7 Million
HLS Therapeutics簡介：2023年第四季度收入爲1,590萬美元，調整後的息稅折舊攤銷前利潤爲530萬美元，運營現金爲370萬美元
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊